| Primary |
| Product Used For Unknown Indication |
29.4% |
| Ill-defined Disorder |
14.3% |
| Pain |
8.1% |
| Nausea |
6.7% |
| Decreased Appetite |
5.5% |
| Muscle Spasticity |
4.3% |
| Constipation |
3.6% |
| Hiv Infection |
3.3% |
| Depression |
3.1% |
| Prophylaxis |
3.1% |
| Vomiting |
2.6% |
| Multiple Sclerosis |
2.4% |
| Pneumonia |
2.4% |
| Renal Pain |
2.1% |
| Back Pain |
1.7% |
| Fibromyalgia |
1.7% |
| Anxiety |
1.4% |
| Bacterial Infection |
1.4% |
| Drug Use For Unknown Indication |
1.4% |
| Insomnia |
1.4% |
|
| Vomiting |
12.5% |
| Urinary Tract Infection |
9.4% |
| Tremor |
7.8% |
| Off Label Use |
6.3% |
| Death |
4.7% |
| Drug Interaction |
4.7% |
| Drug Screen Positive |
4.7% |
| Multiple Sclerosis |
4.7% |
| Multiple Sclerosis Relapse |
4.7% |
| Palpitations |
4.7% |
| Post Procedural Complication |
4.7% |
| Somnolence |
4.7% |
| Therapeutic Response Unexpected |
4.7% |
| Abdominal Pain |
3.1% |
| Decreased Appetite |
3.1% |
| Drug Dependence |
3.1% |
| Drug Ineffective |
3.1% |
| Hallucination |
3.1% |
| Medication Error |
3.1% |
| Mental Status Changes |
3.1% |
|
| Secondary |
| Product Used For Unknown Indication |
37.2% |
| Pain |
10.8% |
| Nausea |
8.3% |
| Hiv Infection |
5.8% |
| Colon Cancer |
4.3% |
| Ill-defined Disorder |
4.2% |
| Vomiting |
3.6% |
| Hypertension |
3.1% |
| Fibromyalgia |
2.9% |
| Crohn's Disease |
2.2% |
| Nephrolithiasis |
2.2% |
| Decreased Appetite |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Neuralgia |
2.0% |
| Depression |
1.8% |
| Bacterial Infection |
1.6% |
| Constipation |
1.6% |
| Multiple Sclerosis |
1.6% |
| Appetite Disorder |
1.4% |
| Asthma |
1.4% |
|
| Tremor |
18.0% |
| Off Label Use |
9.8% |
| Death |
8.2% |
| Drug Interaction |
6.6% |
| Insomnia |
6.6% |
| Vomiting |
6.6% |
| Abdominal Pain |
4.9% |
| Post Procedural Complication |
4.9% |
| Spinal Fracture |
4.9% |
| Ureteric Obstruction |
4.9% |
| Gastric Ulcer |
3.3% |
| Nausea |
3.3% |
| Visual Field Defect |
3.3% |
| Weight Decreased |
3.3% |
| White Blood Cell Count Decreased |
3.3% |
| Bradycardia |
1.6% |
| Convulsion |
1.6% |
| Drug Dependence |
1.6% |
| Drug Hypersensitivity |
1.6% |
| Drug Level Increased |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.2% |
| Drug Use For Unknown Indication |
14.1% |
| Nausea |
10.3% |
| Hiv Infection |
7.4% |
| Pain |
7.0% |
| Non-small Cell Lung Cancer |
5.4% |
| Diffuse Large B-cell Lymphoma |
4.4% |
| Depression |
4.1% |
| Breast Cancer |
2.9% |
| Anxiety |
2.8% |
| Medical Diet |
2.8% |
| Diarrhoea |
2.6% |
| Multiple Myeloma |
2.6% |
| Breast Cancer Metastatic |
2.5% |
| Prophylaxis |
2.5% |
| Hypertension |
2.3% |
| Vomiting |
1.9% |
| Multiple Sclerosis |
1.9% |
| Premedication |
1.6% |
| Arthritis |
1.5% |
|
| Vomiting |
21.8% |
| Weight Decreased |
11.6% |
| Thrombocytopenia |
10.4% |
| Urinary Tract Infection |
7.1% |
| White Blood Cell Count Decreased |
6.5% |
| Pulmonary Embolism |
5.5% |
| Death |
4.7% |
| Syncope |
3.3% |
| Neutropenia |
3.1% |
| Nausea |
2.9% |
| Pain |
2.9% |
| Renal Failure Acute |
2.9% |
| Weight Increased |
2.9% |
| Wound Dehiscence |
2.4% |
| Liver Function Test Abnormal |
2.2% |
| Pleural Effusion |
2.2% |
| Skin Ulcer Haemorrhage |
2.0% |
| Headache |
1.8% |
| Pneumonia |
1.8% |
| Pyrexia |
1.8% |
|
| Interacting |
| Product Used For Unknown Indication |
75.0% |
| Ovarian Cancer |
25.0% |
|
|
